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Summary.-The present study of the effect of heparin and dextran 1000 on the
metastasis formation after i.v. tumour cell injection in dextran non-sensitive rats
using a syngeneic 20-methylcholanthrene induced fibrosarcoma showed that heparin
treatment decreased the formation of pulmonary metastases in animals both un-
treated and treated with dextran 1000. Treatment with dextran 1000 increased the
formation of pulmonary metastases in animals both untreated and treated with
heparin and the effect of dextran 1000 was thus not affected by heparin treatment.
Heparin did not have any direct action on the tumour cells, which influenced
metastasis formation. The data suggest that heparin acts as an anticoagulant with
decreased microthrombus formation around lodged cells and that dextran 1000
stimulates metastasis formation primarily by mechanisms other than intravascular
coagulation.
DIFFERENT kinds of trauma stimulate
metastasis formation after i.v. tumour cell
injection (Agostino and Clifton, 1965;
Boeryd and Rudenstam, 1967; Fisher and
Fisher, 1959; Gelin and Rudenstam, 1966;
el Rifi et al., 1965; Rudenstam, 1968;
Wood, Holyoke and Yardley, 1961).
Intravascular coagulation is one of several
post-traumatic reactions, which has been
considered responsible for this effect of
trauma (Agostino and Cliffton, 1965;
Gelin and Rudenstam, 1966; Robinson
and Hoppe, 1962; Rudenstam, 1968;
Wood et al., 1961). Therefore it has
seemed logical to counteract the effect of
trauma on metastasis formation by the
use of anticoagulants. In earlier studies
Rudenstam (1968) used heparin in com-
bination with a crush fracture trauma,
but no conclusive results were obtained
because a lot of animals deteriorated or
died from severe bleedings in the
traumatized region.
Like trauma, intravenous infusion of
high molecular weight dextran (dextran
1000, mean molecular weight about
1,000,000) induces intravascular coagu-
lation and increased tendency to thrombus
formation (Bergentz, Eiken and Nilsson,
1971; Borgstrom, Gelin and Zederfeldt,
1959; Rudenstam, 1968). Rudenstam
(1968) used dextran 1000 to imitate the
post-traumatic coagulation disturbances
and found that dextran 1000 increased
the formation of pulmonary metastases
after i.v. tumour cell injection. Heparin
reduced the formation of metastases in
both untreated animals and animals given
infusion of dextran 1000. However,
heparin counteracted thestimulatingeffect
of dextran 1000 on metastasis formation
only partially. This suggested that also
mechanisms other than intravascular coag-
ulation, such as disturbed microcirculation
and the anaphylactoid reaction to dextran,
could be of importance for the enhanced
formation of metastases after infusion of
dextran 1000. In Rudenstam's experi-
ments Sprague-Dawley rats were used.
These rats all developed an anaphy-
lactoid reaction against dextran, which
thus might have interferedwiththeresults.
In the present study dextran non-
sensitive rats were used. The purposeHEPARIN, DEXTRAN 1000 AND METASTASIS FORMATION
was to investigate: (1) the formation of
metastases after i.v. tumour cell injection
in animals treated with heparin and
dextran 1000; (2) the formation of metas-
tases after i.v. injection of tumour cells
incubated with heparin.
MATERIALS AND METHODS
Animals.-Inbred rats of a special Wistar
strain resistant to the dextran anaphylactoid
reaction were used. These rats were obtained
from the institute for Research on Animal
Diseases, Compton, England in 1968. A
breeding nucleus was maintained by brother-
sister mating. The age of all experimental
animals was 2-4 months. Animals of the
same sex were always used in one experiment.
The animals were fed on an ad libitum diet of
rat pellets and water. They were housed in
plastic cages, 5-10 animals in each cage and
kept in an air conditioned room at about
220C.
The anaphylactoid reaction, which many
rat strains develop against dextran, is
characterized by hyperaemia, oedema for-
mation of extremities and snout, pruritus,
respiratory distress and lethargy. No such
signs were observed in these dextran non-
sensitive rats after infusion of dextran, nor
did plasma volume determinations (Ivarsson,
Appelgren and Rudenstam, 1975) and fluores-
cein dextran tests (Arfors, 1972) give any
evidence for dextran sensitivity, when per-
formed on these rats after infusion ofdextran.
Tumour.-The tumour studied was a
syngeneic, transplantable, 20-methylchol-
anthrene inducedfibrosarcoma. Thistumour
developed after 5 months in a male rat given
1 mg of 20-methylcholanthrene in 0*5 ml of
sesame oil subcutaneouslv in March 1969.
The tumour was propagated by intramuscular
transfer of a mechanically produced tumour
cell suspension to one hindleg of young rats.
Spontaneous pulmonary metastases occurred
in the transfer animals from the 5th transfer
generation, when a few pulmonary metastases
were observed in some animals dying from
their transplanted tumour after 8-9 weeks.
In the tumour transfer generations used in
this study multiple, small pulmonary meta-
stases appeared 5-6 weeks after tumour trans-
plantation in all animals. No spontaneous
metastases were found in any other organs.
Itisveryunlikelythatspontaneouspulmonary
metastases from the experimentally induced
lung tumours could interfere with the results
in this study as the experimental periods were
20 and 24 days.
Heparin. Commercially available hepa-
rin (Vitrum AB, Stockholm, Sweden), 5000
i.u./ml, was used in a suitable dilution with
normal saline.
Dextran 1000. The dry substance of
this dextran fraction with an average molecu-
lar weight of 1,000,000 was kindly supplied
by Pharmacia AB, Uppsala, Sweden, and a
10% solution in 5-500 glucose was prepared.
Recording of metastases. Animals killed
had a complete autopsy. The lungs were
fixed in formalin and sections prepared at
1200 ,um intervals in the frontal plane. The
areas of lung tissue and metastatic tumour
tissue were then drawn from the microscopic
sections with the aid of a drawing apparatus
adapted to the microscope. Thereafter
these areas were measured planimetrically
and the total areas of lung and metastatic
tumour tissue of each animal were summed
up as was the number of cut metastases
observed in the histological sections of each
animal. From these values the total meta-
stasis volume in cm3 per cm3 lung tissue, the
number ofmetastases per cm3 lung tissue and
the average volume of a single metastasis in
cm3inanimalswithmetastaseswerecalculated
(Boeryd, 1965; Boeryd et al., 1966). Since
these values were distributed in a log-normal
way (Ivarsson and Rudenstam, 1975; Ruden-
stam, 1968) the statistical calculations were
performed on their log-values and the median
values are given in the tables where
V= median total metastasis volume in
cm3 per cm3 lung tissue
N = median number of metastases per
cm3 lung tissue
v = median average volume of a single
metastasis in cm3
The number of animals with pulmonary
metastases out ofthe total number ofanimals
in an experimental group was recorded as the
incidence of pulmonary metastases.
In the firstexperiment (A) thelungweights
also were recorded.
Statistical methods.-When comparing the
lung weight, the volume and the number of
metastases in a control and an experimental
group Student's t-test was used. When 2
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experimental groups were compared, a vari-
ance analysis was performed and differences
between the groups were analysed according
to Scheff6.
All statistical analyses in this investi-
gation were carried out at a 5% level of
significance, i.e. there was a statistically
significant difference when P<0 05.
Experimental procedures
A. Ninety animals were divided randomlyinto
4 groups with 20 animals in Group 1-3 and
30 animals in Group 4.
Group 1.-Controls received saline sub-
cutaneously 2 h before and 5 h after i.v.
injection of tumour cells. Glucose was
infused i.v. 30 min before the injection of
tumour cells.
Group 2.-These animals received heparin
subcutaneously 2 h before and 5 h after the
injection of tumour cells and glucose as in
Group 1.
Group 3.-These received saline as in
Group 1 and dextran 1000 was infused i.v.
30 min before the injection of tumour cells.
Group 4.-The animals in this group
received heparin as in Group 2 and dextran
1000 as in Group 3.
In Group 2 and 4 animals received 200 i.u.
of heparin in a volume of 0-1 ml/100 g body
weight. The dosage of heparin used was
known to give a coagulation time of more
than 30 min for at least 24 h (Rudenstam,
1968). In Groups 1 and 3, saline was given
in a dose of 0-1 ml/100 g body weight to
equal the volume of heparin given in Groups
2 and 4. The glucose solution was 5-5%
and the dose given was 0-75 ml/100 g body
weight. All i.v. injections were given into a
tail vein.
The tumour used was in its 18th transfer
generation. An enzyme disintegrated cell
suspension was prepared as earlier described
(Ivarsson and Rudenstam, 1975). Such a
suspension contained almost 100% single
cells. Some few aggregates of 2-5 cells
remained. The cell viability was estimated
withnigrosinandwasover90%. Thenumber
of living cells given to each animal was
5 x 104. All animals were killed after 24
days by exsanguination following cannulation
of the aorta under ether anaesthesia.
Animals injected extravascularly and animals
that did not survive the first week of the
experimental period were excluded from the
study.
B. Forty animals were randomly divided into
two equal groups:
Group 1.-Controls received incubated
tumour cells intravenously.
Group 2.-These animals received tumour
cells which had been incubated after the
addition of heparin to the cell suspension
intravenously.
The tumour used was in its 29th transfer
generation. An enzyme disintegrated tum-
our cell suspension was prepared as before
and divided into 2 equal parts. To one of
this 20 i.u. of heparin/ml suspension was
added. This amount of heparin gave a
concentrationinthesuspensionwhichequalled
that in the blood after injection of 200 i.u. of
heparin/lO0 gbodyweight. Bothsuspensions
were incubated for 30 min at 37°C. The cell
viability in the suspensions was tested with
nigrosin after the incubation period and was
about 90%. The animals in the first group
were injected i.v. with 6 x 104 cells from
the untreated tumour cell suspension and the
animals in the second group were injected
i.v. with 5-5 x 104 cells from the heparin
treated tumour cell suspension. All injec-
tions were given into a tail vein. All animals
were killed after 20 days by exsanguination
following cannulation ofthe aorta under ether
anaesthesia.
RESULTS
A. The mean lung weight, the incidence
ofmetastases, the median total metastasis
volume, the median number of metastases
and the median average volume of a
single metastasis are presented in Table I.
The lung weight was significantly
decreased by heparin and significantly
increased by dextran 1000. The com-
bined treatment did not change the lung
weight compared with controls. The inci-
denceofmetastaseswas 100%inallgroups.
The total metastasis volume was signifi-
cantly decreased by heparin but was not
influenced significantly by dextran 1000
or the combined treatment. The number
of metastases was significantly decreased
by heparin and significantly increased by
dextran 1000, whereas the combined
treatment did not influence the number
of metastases in a significant way. The
average metastasis volume was not sig-
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TABLE I.-Effect of Heparin and Dextran 1000 on Pulmonary Metastasis Formation
after i.v. Tumour Cell Injection
Procedure
Conitrol
Heparin
Dextran 1000
Heparin + dextran 1000
s
V
N
v
Mean lung
weight (g)
2-76
2 16S
5 16s
2-96
Incidence of
metastases
19/19
18/18
16/16
23/23
V x 104
106-3
36.2s
138-3
84-3
N v x 105
143-6 73 9
50.2s 72- 1
241 - 8s 57- 2
129 - 2 65- 1
significant difference from control; P < 0 05.
median total metastasis volume in cm3 per cm3 lung tissue.
median number of metastases per cm3 lung tissue.
-median average volume of a single metastasis in cm3.
TABLE II.-Effect on Pulmonary Metastasis Formation ofIncubation of
Tumour Cells with Heparin
Procedure
Control
Heparin
V
N
v
Incidence of
metastases
19/20
20/20
V x 103
25-9
27-7
N
17-2
18-4
v X 105
15-0
15-0
median total metastasis volume in cm3 per cm3 lung tissue.
median number of metastases per cm3 lung tissue.
median average volume of a single metastasis in cm3
nificantly influenced by any kind of
treatment.
When the effect of dextran 1000 in
animals treated with heparin was analysed
(heparin comparedwithheparin + dextran
1000) it was evident that both the total
metastasis volume and the number of
metastases were significantly increased by
dextran 1000. On the other hand, heparin
treatment decreased the lung weight, the
total metastasis volume and the number
ofmetastases significantly in animalsgiven
dextran 1000 (dextran 1000 compared with
heparin + dextran 1000). No extra-
pulmonary metastases were observed.
B. The incidence of metastases, the
total metastasis volume, the number of
metastases and the average volume of a
single metastasis are presented in Table II.
There were no differences between the
2 groups in any ofthe recorded parameters
and no extrapulmonary metastases were
observed. Thus, pretreatment of tumour
cells with heparin did not influence the
formation of metastases.
DISCUSSION
These experiments show that short-
term heparin treatment decreased the
35
formation of pulmonary metastases in
animals untreated as well as treated with
dextran 1000. Dextran 1000 treatment
increased the formation of metastases in
animals, both untreated and treated with
heparin. Thus, heparin and dextran 1000
did not influence each other's effect on
metastasis formation. Heparintreatment
did not give rise to extrapulmonary
metastases andpretreatmentofthetumour
cells with heparin did not influence the
formation of metastases.
These results are in agreement with
most earlier reports on the effect of short-
term heparin treatment in both allogeneic
and syngeneic tumour-host systems
(Agostino and Cliffton, 1962, 1965; Cliffton
and Agostino, 1965; Koike, 1963;
Lawrence, Moor and Bernstein, 1953; el
Rifi et al., 1965; Rudenstam, 1968; Sue-
masu and Ishikawa, 1970; Wood et al.,
1961). The incidence and number of
extrapulmonary metastases were investi-
gated especially in some of the studies
mentioned, and were not influenced by
heparin treatment (el Rifi et al., 1965;
Rudenstam, 1968; Wood et al., 1961) or
increased (Lawrence et al., 1953). Koike
(1963) and Wood et al. (1961) also studied
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the effect of incubation of tumour cells
with heparin before tumour cell injection
and did not find any effect of this pro-
cedure. Pretreatment with anticoagu-
lants such as warfarin and dicoumarol
was found to decrease pulmonary metas-
tasis formation after i.v. tumour cell
injection (Agostino and Cliffton, 1962;
Wood et al., 1961).
It is well documented that after the
initial adherence to the vascular endo-
thelium intravenously injected tumour
cells are promptly entrapped by thrombi
composed of platelets and fibrin or a
fibrin-like protein (Gastpar et al., 1961;
Jones, Wallace and Fraser, 1971; Wood,
1958). This microthrombus is considered
by many to be an important and perhaps
necessary prerequisite for the development
of lodged tumour cells into metastases
(Gastpar, 1970; Strauli, 1966; Suemasuand
Ishikawa, 1970; Wood, 1958). Heparin
is supposed to inhibit this microthrombus
formation. It has therefore been assumed
that the effect of heparin on metastasis
formation is due mainly to its anticoagu-
lant ptoperties.
However, other opinions have also
been presented. Boeryd (1965, 1966a,b,
c) concluded that thrombus formation did
not seem to be essential for metastasis
formation and growth. The same opinion
was expressed by Hagmar and Boeryd
(1969). Theyfoundthatthrombusforma-
tion seemed rather to inhibit the estab-
lishment of metastases. Later, Hagmar
and Norrby (1970) arrived at the opinion
thatheparinprobablyinfluencedmetastasis
formation by mechanisms other than
that of impaired blood coagLlation.
Heparin is a potent surfactant. It is
known that heparin can alter membrane
functions and cellular volume (Ambrose,
1967), electrophoretic mobility, adhesive-
ness and possibly the deformation of cells
(Nordling, 1967), ability of cells to
aggregate (Ambrose, Easty and Jones,
1968) and contact between lymphocytes
and target cells (Taylor and Culling, 1966).
Such changes might lead to decreased
lodgement of tumour cells in the pul-
monary circulation. As pointed out
above, however, no evidence of such an
effect of heparin influencing metastasis
formation was obtained in this study and
in studies of Wood et al. (1961) and Koike
(1963).
If heparin counteracts the micro-
thrombus formation aroundlodgedtumour
cells, a decreased lodgement of tumour
cells and possibly also an increased num-
ber of circulating tumour cells might be
expected after heparin treatment of ani-
mals given tumour cells i.v. Koike (1963)
also found an increased number oftumour
cells in the blood after heparin treatment
and i.v. tumour cellinjection, andSuemasu
and Ishikawa (1970) found that tumour
cells passed through the lung more rapidly
and that more tumour cells were found in
the circulating blood after heparin
treatment.
Heparin treatment did not influence
the stimulating effect of dextran 1000 on
metastasis formation. This was evident
from the effect of dextran 1000 when
given to untreated and heparin treated
animals. In both these cases the forma-
tion of metastases was significantly in-
creased when compared with control resp.
heparin treatment alone. This suggested
that intravascular coagulation induced by
dextran 1000 could not be an important
factor behind the stimulation ofmetastasis
formation. Other effects ofdextran 1000,
such as disturbed microcirculation and/or
aggregation of circulating tumour cells,
probably were more important for the
increased metastasis formation than
disturbed coagulation.
Dextran 1000, when given alone,
increased the lung weight and the num-
ber of metastases significantly but did
not increase the total metastasis volume
significantly. This possibly depends on
the fact that the number of metastases
was very large, which might cause a
slowing down of growth.
In Rudenstam's studies (1968) dextran
1000 almost always had a more pro-
nounced effect than in this experiment.
This can probably be explained by the
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anaphylactoid reaction which all rats
developed and which ought to have
potentiated the effect of dextran 1000.
When given to mice which did not develop
any visible signs of an anaphylactoid
reaction, the effect of dextran 1000 on
metastasis formation was about the same
as in this study. Rudenstam found that
heparin in some tumour-host systems
partially counteracted the effectofdextran
1000 on metastasis formation. This can
possibly be explained by an inhibiting
effect of heparin on the intravascular
coagulation, being part of the anaphy-
lactoid reaction.
It is important to point out that the
variable results obtained from different
studies could depend on rather different
characteristics of the many tumour-host
systems used, on different ways of admin-
istration of cells and drugs and on vari-
ation of doses of cells and drugs given.
This study was supported by the
Swedish Cancer Society.
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